On the eve of the European Congress of Pathology in London, new research shows the pathologist's critical role in tackling cancer is not widely understood.
Chalfont St Giles, 29 August 2014 -- As the European Congress of Pathology begins this weekend in London, new research from GE Healthcare shows that many people do not understand the importance of the pathologist in the diagnosis and treatment of breast cancer1, the most common cancer in Europe, with more than 464,000 new cases diagnosed in 2012.2